These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 24051998)

  • 81. Rotavirus vaccination: a concise review.
    Vesikari T
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():57-63. PubMed ID: 22882248
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
    Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
    Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Impact of Routine Rotavirus Vaccination in Germany: Evaluation Five Years After Its Introduction.
    Marquis A; Koch J
    Pediatr Infect Dis J; 2020 Jul; 39(7):e109-e116. PubMed ID: 32187139
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effectiveness of rotavirus vaccine in preventing severe gastroenteritis in young children according to socioeconomic status.
    Gosselin V; Généreux M; Gagneur A; Petit G
    Hum Vaccin Immunother; 2016 Oct; 12(10):2572-2579. PubMed ID: 27367155
    [TBL] [Abstract][Full Text] [Related]  

  • 85. RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.
    Chandran A; Santosham M
    Expert Rev Vaccines; 2008 Dec; 7(10):1475-80. PubMed ID: 19053204
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Burden of paediatric rotavirus gastroenteritis and potential benefits of a universal rotavirus vaccination programme with RotaTeq in France.
    Huet F; Largeron N; Trichard M; Miadi-Fargier H; Jasso-Mosqueda G
    Vaccine; 2007 Aug; 25(34):6348-58. PubMed ID: 17629598
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach.
    Weidemann F; Dehnert M; Koch J; Wichmann O; Höhle M
    Vaccine; 2014 Sep; 32(40):5250-7. PubMed ID: 25045820
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Rotavirus vaccine: a cost effective control measure for India.
    Kumar A; Goel MK; Jain RB; Khanna P; Vibha V
    Hum Vaccin Immunother; 2012 Apr; 8(4):501-4. PubMed ID: 23071989
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen).
    Dennehy PH; Vesikari T; Matson DO; Itzler RF; Dallas MJ; Goveia MG; DiNubile MJ; Heaton PM; Ciarlet M
    Hum Vaccin; 2011 May; 7(5):563-8. PubMed ID: 21441783
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Evidence of herd immunity and sustained impact of rotavirus vaccination on the reduction of rotavirus-related medical encounters among infants from 2006 through 2011 in the United States.
    Mast TC; Wang FT; Su S; Seeger JD
    Pediatr Infect Dis J; 2015 Jun; 34(6):615-20. PubMed ID: 25831421
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Update on Rotarix: an oral human rotavirus vaccine.
    O'Ryan M; Linhares AC
    Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study.
    Vesikari T; Karvonen A; Ferrante SA; Ciarlet M
    Eur J Pediatr; 2010 Nov; 169(11):1379-86. PubMed ID: 20559656
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cost-effectiveness estimates of vaccination against rotavirus in Piedmont, Italy.
    Gualano MR; Thomas R; Gili R; Scaioli G; Voglino G; Zotti C
    J Infect Public Health; 2018; 11(6):867-872. PubMed ID: 30078657
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study.
    Bar-Zeev N; Kapanda L; Tate JE; Jere KC; Iturriza-Gomara M; Nakagomi O; Mwansambo C; Costello A; Parashar UD; Heyderman RS; French N; Cunliffe NA;
    Lancet Infect Dis; 2015 Apr; 15(4):422-8. PubMed ID: 25638521
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain.
    Diez-Domingo J; Suriñach NL; Alcalde NM; Betegón L; Largeron N; Trichard M
    BMC Public Health; 2010 Aug; 10():469. PubMed ID: 20698958
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011.
    Adlhoch C; Hoehne M; Littmann M; Marques AM; Lerche A; Dehnert M; Eckmanns T; Wichmann O; Koch J
    Pediatr Infect Dis J; 2013 Feb; 32(2):e82-9. PubMed ID: 23334342
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain.
    Castilla J; Beristain X; Martínez-Artola V; Navascués A; García Cenoz M; Alvarez N; Polo I; Mazón A; Gil-Setas A; Barricarte A
    Vaccine; 2012 Jan; 30(3):539-43. PubMed ID: 22122860
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effects of the rotavirus vaccine program across age groups in the United States: analysis of national claims data, 2001-2016.
    Baker JM; Dahl RM; Cubilo J; Parashar UD; Lopman BA
    BMC Infect Dis; 2019 Feb; 19(1):186. PubMed ID: 30795739
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Changes in vaccine coverage and incidence of acute gastroenteritis and severe rotavirus gastroenteritis in children <5 years in Shibata City, Niigata Prefecture, Japan.
    Oishi T; Hasegawa S; Nakano T; Sudo S; Kuwajima H; Tokuriki S; Tamura T
    Hum Vaccin Immunother; 2024 Dec; 20(1):2322202. PubMed ID: 38478958
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccination.
    Donato CM; Ch'ng LS; Boniface KF; Crawford NW; Buttery JP; Lyon M; Bishop RF; Kirkwood CD
    J Infect Dis; 2012 Aug; 206(3):377-83. PubMed ID: 22615314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.